Picture of Zeria Pharmaceutical logo

4559 — Zeria Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Zeria Pharm -9-MTH group results

Feb 8 (Reuters)-  
             Zeria Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             49.04               47.05            66.00     
                 (+4.2 pct)          (+2.8 pct)       (+5.6 pct)   
  Operating          3.64                3.79             4.80     
                 (-4.0 pct)          (+13.5 pct)      (+5.1 pct)   
  Recurring          3.50                3.77             4.60     
                 (-7.0 pct)          (+13.0 pct)      (+3.4 pct)   
  Net                2.87                3.34             3.60     
                 (-13.8 pct)         (+5.5 pct)       (+2.5 pct)   
  EPS             54.10 yen           62.79 yen        67.78 yen   
  Ann Div                             31.00 yen        32.00 yen   
  -Q2 div         16.00 yen           15.00 yen                    
  -Q4 div                             16.00 yen        16.00 yen   
   
  NOTE - Zeria Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Zeria Pharmaceutical

See all news